NAGENpediatrics - Advanced genomic sequencing in pediatrics

The NAGENpediatrics project allows genome analysis to be implanted in the pediatric clinical practice of the University Hospital of Navarre. This project sequences the genome of newborn children who test positive for heel or suspected of a previously undetected genetic disease. The results are obtained in about 20 days and allows to advance treatment reducing the risk of increased disability or even death.
The coordination of the project lays on the Genomic Medicine Research Unit, by Josune Hualde Olascoaga, Principal Investigator of the project in collaboration with the Pediatric Service of the University Hospital of Navarra (HUN).
Navarrabiomed leads the NAGENpediatrics project, an initiative approved by the Government of Navarra in the call for Grants to carry out strategic R&D projects 2020-2022 in the GEMA challenge of Genomics and Advanced Medicine. This call finances cutting-edge R&D projects in areas and challenges of special interest to society and to Navarre.
Since the year 2016 Navarrabiomed leads the Navarra Strategy in Genomic Medicine of the SNS-O (NAGEN). Since then, and thanks to the support of the Government of Navarra, the centre has promoted the development of six strategic projects: ReproNAGEN, NAGENMx, NAGENCOL, NAGENPediatrics, Pharmanagen and NAGEN1000. The common denominator of all these projects is the use of the information contained in the human genome to improve the management and treatment of SNS-O patients.
These initiatives, together with ReproNAGEN, are making it possible to implement the necessary infrastructures in the SNS-O healthcare circuit so that the information contained in the genome can be used as a method for the diagnosis and treatment of diseases.

[@iolandevandertuig5938]

Promo`SM 😡